AUS
NZ
UK
CA
USA
IND
Healt
From Metcash to Ansell: 5 ASX healthcare mid-cap shares in focus
February 16, 2022 01:37 PM AEDT| By Team Kalkine MediaOn the Australian Securities Exchange (ASX), mid-cap stocks are the stocks whose market capitalisation ranges from AU$2 billion to AU$10 billion, i.e., these stocks fall between the small-cap and large-cap categories. Mid-cap stocks are favourite .....
Crypto Kings: Extraordinary Tale of Coinbase Founders Brian Armstrong, Fred Ehrsam
April 15, 2021 07:18 PM AEST| By Team Kalkine MediaSource: DSkorynko, Shutterstock Summary Although Coinbase made a smashing debuted on NASDAQ, opening 4% higher than the reference price, the Company had humble beginnings. Co-founders Fred Ehrsam and Brian Armstrong met on Reddit and built the...
Why Oceania (ASX:OCA) shares might be on the move today
April 15, 2021 08:24 AM AEST| By AshishOceania Healthcare Ltd (ASX:OCA, NZX:OCA) on Thursday announced that its non-underwritten retail offer was well received by shareholders and has closed oversubscribed. The company received over 5000 applications totalling nearly NZ$50 million for...
A Comprehensive Guide for the Perfect Online Physiotherapy Services
January 13, 2021 03:18 PM AEDT| By Team Kalkine MediaPhysiotherapy is a treatment that intends to help people move freely and with less or no pain, by using physical methods like massage and exercise rather than treatments or surgeries. It is the process used for the treatment of any indication, injury...
A detailed guide to picking the perfect health insurance plan
December 11, 2020 11:46 PM AEDT| By Team Kalkine MediaHealth insurance is considered a vital part of an individual’s health. At times, medical treatments, related to an accident or an illness, can be extremely expensive, and lead to financial instability. With health insurance, one can minimise t...
UK First Nation To Approve Pfizer-BioNTech COVID-19 Vaccine, Roll Out ‘Next Week'
December 02, 2020 06:53 PM AEDT| By Team Kalkine MediaIn a major development, the United Kingdom on Wednesday became the first nation to approve the Pfizer-BioNTech vaccination for public use. The COVID-19 mRNA vaccine candidate will be rolled out from next week, informed UK health secretary Matt Hancoc...
What are Public health initiatives in Australia?
November 20, 2020 01:39 PM AEDT| By Team Kalkine MediaAustralia’s healthcare system is one of the most comprehensive ones across the world, offering a wide assortment of services. Right from general and preventive health, to the treatment of more complicated and serious conditions, the Australia.....
Why is family health insurance important? What to consider while choosing one?
November 12, 2020 12:25 AM AEDT| By Team Kalkine MediaIn Australia, Medicare covers most of the healthcare related-needs. However, there are some exceptions, such as dental care, glasses and contacts, physiotherapy, and ambulance services. These services, if availed, can create a deep hole in your poc.....
GE Healthcare in partnership with GenesisCare to deliver improved Cancer and Cardiovascular treatments
November 10, 2020 03:33 PM AEDT| By Hina ChowdharyGE Healthcare is the healthcare division of the American multinational conglomerate, General Electric (NYSE: GE). The division alone is valued at US$16.7 billion and provides medical technology and related digital solutions on a global scale. .....
Public vs Private Health Insurance in Australia
November 06, 2020 01:55 AM AEDT| By Edita IvancevicSticking to your public insurance or getting a new private health policy with a range of benefits is one of the most critical doubts Australians have before they turn 31. When the government introduced the Lifetime Health Cover (LHC), more youngst.....
CLINUVEL’s Share Price Up ~9%, What Pushed the ASX 200 Healthcare Stock north?
September 10, 2020 07:10 PM AEST| By Team Kalkine MediaSummary ASX 200 company CLINUVEL PHARMACEUTICALS LTD disclosed the progression of SCENESSE® (afamelanotide 16 mg) for the treatment of xeroderma pigmentosum. Following the announcement CLINUVEL share price skyrocketed, ending the session at.....
Imugene Secures Option Underwriting Agreement with Bell Potter to Raise $5.7 Million
September 10, 2020 12:50 PM AEST| By Team Kalkine MediaNSW-headquartered clinical stage immuno-oncology firm, Imugene Limited (ASX:IMU) has secured an underwriting agreement with Bell Potter Securities Limited with institutional investors to underwrite the balance of options not exercised by 30 Novembe.....
SUDA Secures Australian Patent Office’s Approval on Anagrelide Cancer Patent
September 09, 2020 02:17 PM AEST| By Team Kalkine MediaSummary SUDA’s share price soared by ~12% on securing approval for anagrelide cancer patent in Australia. With the Australian Patent Office accepting the patent application, the anagrelide patent will now proceed to grant. The approval o.....
Imugene Attains First US Ethics Approval from WIRB to Begin PD1-Vaxx’s Phase I trial
September 08, 2020 12:59 PM AEST| By Team Kalkine MediaAustralia-based immuno-oncology company Imugene Limited (ASX:IMU) has recently marked a great leap forward by attaining the first ethics approval in the US to kick-start Phase I trial of new cancer immunotherapy, PD1-Vaxx. The approval has been rec.....
ASX 200 Biotech Major CSL Inks Two Deals to Manufacture COVID-19 Vaccines in Australia
September 07, 2020 05:57 PM AEST| By Team Kalkine MediaSummary Governments in several countries are securing early access of COVID-19 vaccine by signing deals with the frontrunners. ASX 200 biotech player, CSL Limited had signed two Heads of Agreement to manufacture and supply COVID-19 vaccine acro.....
ASX Share Price to Watch - Telix Pharmaceuticals; announces prostate cancer imaging partnership, receives ODD for TLX102
September 05, 2020 12:15 AM AEST| By Team Kalkine MediaSummary ASX-listed biopharmaceutical player Telix Pharmaceuticals announced a strategic collaboration agreement with Palo Alto-based Varian Medical Systems on 3 September. Through the collaboration, the two parties will evaluate the use of adva.....
Noxopharm to Commence Veyonda®’s Clinical Trial in COVID-19 Patients in Europe
September 04, 2020 01:45 PM AEST| By Team Kalkine MediaAustralian biotech, Noxopharm Limited (ASX:NOX) has announced an important milestone with formal approval for immediate initiation of Veyonda®’s clinical trial in COVID-19 patients in Europe. Following the key update, the Company’s.....
Starpharma bags A$1 million funding for COVID-19 spray - a shot in the arm for the ASX300 Player?
September 03, 2020 05:36 PM AEST| By Team Kalkine MediaSummary ASX 300 listed healthcare player Starpharma Holdings Limited receives A$1 million funding from MRFF for its SPL7013 COVID-19 nasal spray. The Company intends to utilise the funds to accelerate the development and commercialisation .....
Has the ASX 200 Healthcare Stock Mesoblast Touched a new 52-week high?
September 02, 2020 06:31 PM AEST| By Team Kalkine MediaSummary Australian regenerative medicine company Mesoblast’s share price hit a 52-week high on 27 August following outstanding FY2020 results with revenue up 92%. Mesoblast, on 2 September, received ethics approval to include Australian h.....
Imugene’s FY20 Report Card Out, Outlines Notable Operational Achievements
September 02, 2020 01:20 PM AEST| By Team Kalkine MediaIn a latest update, the biotech company Imugene Limited (ASX:IMU) has published its Annual Report for the year ended 30th June 2020 on the ASX. The financial year 2020 has been a remarkable one for Imugene, experiencing significant change and growt.....
Advertise your brand on Kalkine Media